文献速递生殖医学

HaploSeek联合PGT-A与PGT-M分析改善单基因病夫妇的周期结局

Improved cycle outcomes using the HaploSeek comprehensive PGT-A and PGT-M combined analysis in monogenic-disease-affected couples.
PubMed 文献 · Reprod Biomed Online · 2026-07-30

这项回顾性队列研究比较了HaploSeek方法(PGT-M联合PGT-A)与单独PGT-M在单基因病夫妇IVF周期中的临床结局。研究纳入年龄≤42岁、至少有一个囊胚的患者,分析显示HaploSeek组首次取卵的活产率更高(35.6% vs 16.7%,P=0.0181),每次移植的活产率也显著更高(P=0.02),而累积活产率两组相似。

要点

  • HaploSeek组首次取卵的活产率为35.6%,显著高于单独PGT-M组的16.7%。
  • 每次移植的活产率在HaploSeek组显著更高(P=0.02)。
  • 两组累积活产率相似,且可移植胚胎数无显著差异。

核心结论

  • HaploSeek联合PGT-M和PGT-A可能显著提高每次移植的活产率,且不降低累积活产率。

研究设计与样本

  • 回顾性队列研究,纳入年龄≤42岁、至少有一个囊胚的行IVF-PGT-M的患者。
  • 对照组54例患者(平均年龄33.4±4.5岁,P=0.57)共84次取卵,仅接受PGT-M(采用短串联重复序列连锁分析)。
  • 分析分为四个层次:每名女性(首次取卵和首次移植,主要结局为活产率)、每次取卵(所有取卵,主要结局为可移植胚胎数)、每次胚胎移植(所有移植,主要结局为活产率)、每次信息性取卵(患者分娩或完成所有胚胎移植的取卵,计算累积活产率)。

主要发现

  • 每名女性首次取卵的活产率:研究组35.6% vs 对照组16.7%(P=0.0181)。
  • 每次取卵的可活检胚胎数:研究组3.99±3.1 vs 对照组3.75±4.14(P=0.34)。
  • 每次取卵的可移植胚胎数:研究组1.29±1.52(32.3%)vs 对照组1.69±2.37(45.1%)(P=0.075)。
  • 多变量逻辑回归显示,HaploSeek和年龄与首次取卵活产概率升高相关。
  • 每次移植的活产率:研究组显著高于对照组(P=0.02)。

临床怎么用

  • 对于单基因病夫妇,采用HaploSeek联合PGT-M和PGT-A可能提高每次移植的活产率,且不降低累积活产率。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RESEARCH QUESTION: Is there a difference in clinical outcomes of IVF cycles using the HaploSeek method [preimplantation genetic testing for monogenic conditions (PGT-M) combined with preimplantation genetic testing for aneuploidy (PGT-A)] compared with clinical outcomes of IVF cycles using PGT-M alone? DESIGN: This retrospective cohort study included patients aged ≤42 years undergoing IVF PGT-M with at least one blastocyst. The study group underwent HaploSeek, combining PGT-M and PGT-A. The control group underwent PGT-M alone, using short tandem repeat linkage. Analysis was performed following stratification into four groups: per woman, including the first retrieval and first transfer, with live birth rate (LBR) as the primary outcome; per retrieval, all retrievals, with the number of embryos available for transfer as the primary outcome; per embryo transfer, all transfers, with LBR as the primary outcome; and per informative retrieval, all retrievals in which the patient delivered or completed transfer of all embryos, calculating cumulative LBR (CLBR). RESULTS: Seventy-three patients (mean ± SD age 33.5 ± 4.4 years) undergoing 128 retrievals were included in the study group. The control group consisted of 54 patients (mean ± SD age 33.4 ± 4.5 years; P = 0.57) undergoing 84 retrievals. The number of embryos available for biopsy per retrieval was similar between the study and control groups (mean ± SD 3.99 ± 3.1 versus 3.75 ± 4.14; P = 0.34), as was the number of transferable embryos per retrieval [mean ± SD 1.29 ± 1.52 (32.3%) versus 1.69 ± 2.37 (45.1%); P = 0.075]. LBR was higher per first retrieval per woman in the study group (35.6% versus 16.7%; P = 0.0181). A multivariable logistic regression for LBR in the first retrieval showed that HaploSeek and age were associated with higher probability of live birth. Per-transfer analysis revealed that LBR was significantly higher in the study group (P = 0.02). CLBR per informative retrieval was similar between groups. CONCLUSIONS: HaploSeek, evaluating both PGT-M and PGT-A, may significantly improve LBR per transfer without reducing CLBR in comparison with PGT-M alone in couples with monogenic diseases.

来源:Reprod Biomed Online,查看原文。版权归原作者所有。

引用

  1. Youngster M, Granot I, Eizenman E, et al. Improved cycle outcomes using the HaploSeek comprehensive PGT-A and PGT-M combined analysis in monogenic-disease-affected couples. Reprod Biomed Online. 2026. PMID: 42636753. doi:10.1016/j.rbmo.2026.105890

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。